Search Results - "Stefani, Stephen"

Refine Results
  1. 1
  2. 2
  3. 3

    The Value of Biomarkers in Optimizing the Use of Immuno-oncologic Therapy by Ferreira, Carlos G, Nicolini, Andrea, Dalurzo, Liliana, Stefani, Stephen, Teich, Vanessa, Leighl, Natasha

    Published in Current drug targets (01-01-2019)
    “…The development of therapies that restore or activate the host immune response - the socalled "immuno-oncologic" therapy - has improved the survival of some…”
    Get more information
    Journal Article
  4. 4

    Brazilian health-care policy for targeted oncology therapies and companion diagnostic testing by Ferreira, Carlos Gil, Dr, Achatz, Maria Isabel, MD, Ashton-Prolla, Patricia, MD, Begnami, Maria Dirlei, MD, Marchini, Fabricio K, PhD, Stefani, Stephen Doral, MD

    Published in The lancet oncology (01-08-2016)
    “…Summary A growing understanding of the molecular pathology of tumours combined with a surge of new drugs and associated diagnostic technologies (ie, precision…”
    Get full text
    Journal Article
  5. 5
  6. 6

    BRAF Testing in Melanoma and Colorectal Cancer in Latin America: Challenges and Opportunities by Peixoto, Renata D, Chakhtoura, Jad Joseph Abbas, Aguilar-Ponce, José L, Garcia-Rivello, Hernan, Jansen, Angela M, Parra Medina, Rafael, Ramos-Esquivel, Allan, Stefani, Stephen Doral

    Published in Curēus (Palo Alto, CA) (28-11-2022)
    “…The incidence of colorectal cancer in Argentina and Brazil has reached levels comparable to those in higher-income countries. Similarly, the incidence of…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    A call to action: molecular pathology in Brazil by da Cunha, Isabela Werneck, de Almeida Coudry, Renata, de Macedo, Mariana Petaccia, de Assis, Emilio Augusto Campos Pereira, Stefani, Stephen, Soares, Fernando Augusto

    Published in Surgical and experimental pathology (11-10-2021)
    “…Abstract Background Adoption of molecular pathology in Brazil is currently very limited. Of note, there are no programs for training new molecular pathologists…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Evolution of cancer treatment costs in the last 36 months in a self-funded health care in Brazil by Reis Neto, Joao Paulo, Busch, Juliana Martinho, Stefani, Stephen

    Published in Journal of clinical oncology (01-06-2023)
    “…e18838 Background: In Brazil, cancer, in addition to being one of the main causes of illness and death, represents one of the highest public and private…”
    Get full text
    Journal Article
  15. 15

    Cost-minimisation analysis of erlotinib in the second-line treatment of non-small-cell lung cancer: a Brazilian perspective by Doral Stefani, Stephen, Giorgio Saggia, Mario, Vicino dos Santos, Eduardo Augustus

    Published in Journal of medical economics (2008)
    “…A cost-minimisation and budget impact analysis of erlotinib versus docetaxel or pemetrexed as second-line treatment for advanced non-small-cell lung cancer…”
    Get more information
    Journal Article
  16. 16

    Delivering precision oncology to patients with cancer by Mateo, Joaquin, Steuten, Lotte, Aftimos, Philippe, André, Fabrice, Davies, Mark, Garralda, Elena, Geissler, Jan, Husereau, Don, Martinez-Lopez, Iciar, Normanno, Nicola, Reis-Filho, Jorge S., Stefani, Stephen, Thomas, David M., Westphalen, C. Benedikt, Voest, Emile

    Published in Nature Medicine (01-04-2022)
    “…With the increasing use of genomic profiling for diagnosis and therapy guidance in many tumor types, precision oncology is rapidly reshaping cancer care…”
    Get full text
    Journal Article Magazine Article
  17. 17

    Enhancing colon cancer care in restricted-resource settings by Von Wallwitz Freitas, Laura, Stefani, Stephen

    Published in The lancet oncology (01-06-2023)
    “…Colon cancer ranks third among the most frequently diagnosed cancers worldwide and was projected to claim more than 900 000 lives in 2020, according to the…”
    Get full text
    Journal Article
  18. 18

    All-cause and cancer mortality in a private health plan in Brazil: Ten years retrospective analysis by Reis Neto, Joao Paulo, Busch, Juliana Martinho, Stefani, Stephen D.

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only e13610 Background: Cancer is the second leading cause of death worldwide. From 2014 to 2015 Brazil estimated more than 500,000 new cases of…”
    Get full text
    Journal Article
  19. 19

    Adverse event management costs for first-line treatment with cetuximab or panitumumab of RAS wild-type metastatic colorectal cancer patients in Latin America by Pescott, Chris, Kasle, Adam, Esteso, Federico, Stefani, Stephen, Brust, Leandro, Pinto, Jose, Tilli, Malena, Massello, Matthew

    Published in Journal of clinical oncology (01-02-2022)
    “…Abstract only 203 Background: Anti-EGFR treatment of RAS wild-type metastatic colorectal cancer (mCRC) in Latin America includes cetuximab or panitumumab,…”
    Get full text
    Journal Article
  20. 20